{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:03:54Z","timestamp":1793347434865,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100016820","name":"Vaccine Research Center","doi-asserted-by":"publisher","award":["U54 CA260543"],"award-info":[{"award-number":["U54 CA260543"]}],"id":[{"id":"10.13039\/100016820","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016820","name":"Vaccine Research Center","doi-asserted-by":"publisher","award":["U01 AI149644"],"award-info":[{"award-number":["U01 AI149644"]}],"id":[{"id":"10.13039\/100016820","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 CA260543"],"award-info":[{"award-number":["U54 CA260543"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AI149644"],"award-info":[{"award-number":["U01 AI149644"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54 CA260543"],"award-info":[{"award-number":["U54 CA260543"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01 AI149644"],"award-info":[{"award-number":["U01 AI149644"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U54 CA260543"],"award-info":[{"award-number":["U54 CA260543"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI149644"],"award-info":[{"award-number":["U01 AI149644"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.immuni.2021.06.018","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T04:21:12Z","timestamp":1625199672000},"page":"1869-1882.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge"],"prefix":"10.1016","volume":"54","author":[{"given":"Anthony T.","family":"DiPiazza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Leist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olubukola M.","family":"Abiona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan I.","family":"Moliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Minai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca M.","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin W.","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Phung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Kenneth H.","family":"Dinnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Loomis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyhan","family":"Boyoglu-Barnum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela S.","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darin K.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn M.","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Mascola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Carfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kizzmekia S.","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian N.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph S.","family":"Baric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barney S.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy J.","family":"Ruckwardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2021.06.018_bib1","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults","volume":"383","author":"Anderson","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2021.06.018_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41586-020-2538-8","article-title":"A perspective on potential antibody-dependent enhancement of SARS-CoV-2","volume":"584","author":"Arvin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2021.06.018_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2021.06.018_bib4","doi-asserted-by":"crossref","first-page":"12201","DOI":"10.1128\/JVI.06048-11","article-title":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge","volume":"85","author":"Bolles","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2021.06.018_bib5","doi-asserted-by":"crossref","first-page":"9896","DOI":"10.1128\/JVI.01118-06","article-title":"Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium","volume":"80","author":"B\u00f6ttcher","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2021.06.018_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2598-9","article-title":"SARS-CoV-2-reactive T\u00a0cells in healthy donors and patients with COVID-19","volume":"587","author":"Braun","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2021.06.018_bib7","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of mouse and human IgG receptors and their contribution to disease models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2021.06.018_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa2029849","article-title":"SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19","volume":"384","author":"Chen","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2021.06.018_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41577-020-0402-6","article-title":"T cell responses in patients with COVID-19","volume":"20","author":"Chen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2021.06.018_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0065-2776(08)60536-2","article-title":"Mechanism and regulation of immunoglobulin isotype switching","volume":"54","author":"Coffman","year":"1993","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.immuni.2021.06.018_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.15.1.297","article-title":"Induction of Th1 and Th2 CD4+ T\u00a0cell responses: the alternative approaches","volume":"15","author":"Constant","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2021.06.018_bib12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2021.06.018_bib13","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates","volume":"383","author":"Corbett","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2021.06.018_bib14","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2021.06.018_bib15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.4049\/jimmunol.1600318","article-title":"A cytokine-independent approach to identify antigen-specific human germinal center T follicular helper cells and rare antigen-specific CD4+ T\u00a0cells in blood","volume":"197","author":"Dan","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2021.06.018_bib16","doi-asserted-by":"crossref","first-page":"eabf4063","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8\u00a0months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.immuni.2021.06.018_bib17","first-page":"849573","article-title":"Epigenetic control of interferon-gamma expression in CD8 T\u00a0cells","volume":"2015","author":"de Ara\u00fajo-Souza","year":"2015","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.immuni.2021.06.018_bib18","doi-asserted-by":"crossref","first-page":"11561","DOI":"10.1128\/JVI.76.22.11561-11569.2002","article-title":"Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection","volume":"76","author":"De Swart","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2021.06.018_bib19","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1371\/journal.pmed.0030525","article-title":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants","volume":"3","author":"Deming","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.immuni.2021.06.018_bib20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41586-020-2708-8","article-title":"A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures","volume":"586","author":"Dinnon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2021.06.018_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbrc.2020.10.060","article-title":"T cell immunity to SARS-CoV-2 following natural infection and vaccination","volume":"538","author":"DiPiazza","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.immuni.2021.06.018_bib22","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/jama.1967.03130250057008","article-title":"Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines","volume":"202","author":"Fulginiti","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.immuni.2021.06.018_bib23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.abb8923","article-title":"Rapid COVID-19 vaccine development","volume":"368","author":"Graham","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2021.06.018_bib24","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.4049\/jimmunol.151.4.2032","article-title":"Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus","volume":"151","author":"Graham","year":"1993","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2021.06.018_bib25","doi-asserted-by":"crossref","first-page":"eabe0948","DOI":"10.1126\/scitranslmed.abe0948","article-title":"Prospects for a safe COVID-19 vaccine","volume":"12","author":"Haynes","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2021.06.018_bib26","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1128\/JVI.02980-14","article-title":"Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology","volume":"89","author":"Honda-Okubo","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2021.06.018_bib27","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 - preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2021.06.018_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2020.12.009","article-title":"T cell memory: understanding COVID-19","volume":"54","author":"Jarjour","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2021.06.018_bib29","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1128\/JVI.73.10.8485-8495.1999","article-title":"Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism","volume":"73","author":"Johnson","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2021.06.018_bib30","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.4049\/jimmunol.170.4.2037","article-title":"IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge","volume":"170","author":"Johnson","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2021.06.018_bib31","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1128\/JVI.78.11.6024-6032.2004","article-title":"Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV","volume":"78","author":"Johnson","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2021.06.018_bib32","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","article-title":"Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine","volume":"383","author":"Keech","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2021.06.018_bib33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.immuni.2021.06.018_bib34","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.immuni.2020.07.019","article-title":"A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice","volume":"53","author":"Laczk\u00f3","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2021.06.018_bib35","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1016\/j.vaccine.2020.05.064","article-title":"Consensus summary report for CEPI\/BC March 12-13, 2020 meeting: assessment of risk of disease enhancement with COVID-19 vaccines","volume":"38","author":"Lambert","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2021.06.018_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4049\/jimmunol.2001067","article-title":"Systematic examination of antigen-specific recall T\u00a0cell responses to SARS-CoV-2 versus influenza virus reveals a distinct inflammatory profile","volume":"206","author":"Law","year":"2021","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2021.06.018_bib37","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.immuni.2020.11.009","article-title":"SARS-CoV-2 mRNA vaccines foster potent antigen-specific germinal center responses associated with neutralizing antibody generation","volume":"53","author":"Lederer","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2021.06.018_bib38","doi-asserted-by":"crossref","first-page":"e20201254","DOI":"10.1084\/jem.20201254","article-title":"Modulating the quantity of HIV Env-specific CD4 T\u00a0cell help promotes rare B cell responses in germinal centers","volume":"218","author":"Lee","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2021.06.018_bib39","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.cell.2020.09.050","article-title":"A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice","volume":"183","author":"Leist","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2021.06.018_bib40","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41577-020-00460-4","article-title":"Cross-reactive memory T\u00a0cells and herd immunity to SARS-CoV-2","volume":"20","author":"Lipsitch","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2021.06.018_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12026-009-8098-5","article-title":"T helper cytokine patterns: defined subsets, random expression, and external modulation","volume":"45","author":"Mosmann","year":"2009","journal-title":"Immunol. Res."},{"key":"10.1016\/j.immuni.2021.06.018_bib42","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1016\/j.vaccine.2021.01.055","article-title":"Vaccine-associated enhanced disease: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"39","author":"Munoz","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2021.06.018_bib43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0022-3476(68)80396-8","article-title":"Atypical exanthem following exposure to natural measles: eleven cases in children previously inoculated with killed vaccine","volume":"72","author":"Nader","year":"1968","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.immuni.2021.06.018_bib44","doi-asserted-by":"crossref","first-page":"11382","DOI":"10.1073\/pnas.93.21.11382","article-title":"Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector","volume":"93","author":"Naldini","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2021.06.018_bib45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.vaccine.2018.11.024","article-title":"Interferon gamma (IFN-\u03b3) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigens","volume":"37","author":"Nakiboneka","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2021.06.018_bib46","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2021.06.018_bib47","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2021.06.018_bib48","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1073\/pnas.2005456117","article-title":"News feature: avoiding pitfalls in the pursuit of a COVID-19 vaccine","volume":"117","author":"Peeples","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2021.06.018_bib49","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","article-title":"Broad and strong memory CD4+ and CD8+ T\u00a0cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19","volume":"21","author":"Peng","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2021.06.018_bib50","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nm918","article-title":"A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles","volume":"9","author":"Polack","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2021.06.018_bib51","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.immuni.2019.08.007","article-title":"Immunological lessons from respiratory syncytial virus vaccine development","volume":"51","author":"Ruckwardt","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2021.06.018_bib52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.chom.2021.02.002","article-title":"Virus vaccines: proteins prefer prolines","volume":"29","author":"Sanders","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2021.06.018_bib53","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T\u00a0cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2021.06.018_bib54","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3389\/fmicb.2018.02991","article-title":"Viral-induced enhanced disease illness","volume":"9","author":"Smatti","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.immuni.2021.06.018_bib55","article-title":"A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates","author":"Vogel","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.immuni.2021.06.018_bib56","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2021.06.018_bib57","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa2035002","article-title":"REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19","volume":"384","author":"Weinreich","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2021.06.018_bib58","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1084\/jem.20041463","article-title":"Interferon-gamma acts directly on CD8+ T\u00a0cells to increase their abundance during virus infection","volume":"201","author":"Whitmire","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2021.06.018_bib59","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJMc2032195","article-title":"Durability of responses after SARS-CoV-2 mRNA-1273 vaccination","volume":"384","author":"Widge","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2021.06.018_bib60","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2021.06.018_bib61","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/eji.200424939","article-title":"Synthesis of several chemokines but few cytokines by primed uncommitted precursor CD4 T\u00a0cells suggests that these cells recruit other immune cells without exerting direct effector functions","volume":"34","author":"Yang","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2021.06.018_bib62","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.4049\/jimmunol.181.9.6337","article-title":"Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV","volume":"181","author":"Yasui","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2021.06.018_bib63","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/14760584.2020.1800463","article-title":"Vaccination against SARS-CoV-2 and disease enhancement - knowns and unknowns","volume":"19","author":"Zellweger","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.immuni.2021.06.018_bib64","doi-asserted-by":"crossref","first-page":"108322","DOI":"10.1016\/j.celrep.2020.108322","article-title":"Structure-based design with tag-based purification and in-process biotinylation enable streamlined development of SARS-CoV-2 spike molecular probes","volume":"33","author":"Zhou","year":"2020","journal-title":"Cell Rep."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761321002624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761321002624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:15:10Z","timestamp":1761034510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761321002624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":64,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1074761321002624"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2021.06.018","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740403173.793587952","asserted-by":"object"}]},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2021.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}